Hiroyuki Shibata

Professor

Akita University

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Immunology Immunology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Hiroyuki Shibata is a Professor at Akita University in Japan. His research areas include cancer immunotherapy, molecular tumor profiling, and the pharmacological effects of curcumin. He has recently published articles on topics such as Lynch syndrome, advanced colorectal cancer treatment, and the role of curcumin in enhancing the efficacy of cancer therapies.

Articles (10)

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (4)

Hidetaka Niizuma

Assistant Professor

Tohoku University Hospital

JAPAN

View details

Kanami Orihara

Associate Professor

Tokyo Institute of Technology

JAPAN

View details

Takashi MaruYama

National Institutes of Health

UNITED STATES

View details

Hiroshi Tada

Associate Professor

Tohoku University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Hiroyuki Shibata

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Clinical decisions by the molecular tumor board on comprehensive genomic profiling tests in Japan: A retrospective observational study

A novel Lynch syndrome pedigree bearing germ-line MSH2 missense mutation c.1808A>T (Asp603Val)

Curcumin affects function of Hsp90 and drug efflux pump of Candida albicans

TGF-β and Cancer Immunotherapy

Two Cases of ALK-Altered Cancers of Unknown Primary Diagnosed by Immunohistochemistry

Clinical efficacy and safety of second line and salvage aflibercept for advanced colorectal cancer in Akita prefecture

Curcumin analog GO-Y030 boosts the efficacy of anti-PD-1 cancer immunotherapy

Phase II study of trifluridine/tipiracil (TAS-102) therapy in elderly patients with colorectal cancer (T-CORE1401): geriatric assessment tools and plasma drug concentrations as possible predictive biomarkers

The Curcumin Analog GO-Y030 Controls the Generation and Stability of Regulatory T Cells

Clinical benefits of adjuvant chemotherapy with carboplatin and gemcitabine in patients with non-small cell lung cancer: A single-center retrospective study

Collaborators (4)

Hidetaka Niizuma

Kanami Orihara

Takashi MaruYama

Hiroshi Tada

Make your next move.

Hiroyuki Shibata

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Clinical decisions by the molecular tumor board on comprehensive genomic profiling tests in Japan: A retrospective observational study

A novel Lynch syndrome pedigree bearing germ-line MSH2 missense mutation c.1808A&gt;T (Asp603Val)

Curcumin affects function of Hsp90 and drug efflux pump of Candida albicans

TGF-β and Cancer Immunotherapy

Two Cases of ALK-Altered Cancers of Unknown Primary Diagnosed by Immunohistochemistry

Clinical efficacy and safety of second line and salvage aflibercept for advanced colorectal cancer in Akita prefecture

Curcumin analog GO-Y030 boosts the efficacy of anti-PD-1 cancer immunotherapy

Phase II study of trifluridine/tipiracil (TAS-102) therapy in elderly patients with colorectal cancer (T-CORE1401): geriatric assessment tools and plasma drug concentrations as possible predictive biomarkers

The Curcumin Analog GO-Y030 Controls the Generation and Stability of Regulatory T Cells

Clinical benefits of adjuvant chemotherapy with carboplatin and gemcitabine in patients with non-small cell lung cancer: A single-center retrospective study

Collaborators (4)

Hidetaka Niizuma

Kanami Orihara

Takashi MaruYama

Hiroshi Tada

Make your next move.

A novel Lynch syndrome pedigree bearing germ-line MSH2 missense mutation c.1808A>T (Asp603Val)